Technology Transfer News

Tuesday, 23 January 2018

New spin-off Ahead Therapeutics SL to develop novel therapies for autoimmune diseases

Ahead Therapeutics SL is the result of a joint research project with a strong nano component between the Germans Trias i Pujol Research Institute (IGTP), the ICN2 and ICREA. It was created to advance the development of therapies for autoimmune diseases and pursue their application in a clinical setting. Just a few months in, the new company has already attracted 1.1 million euros in private investment.

Tuesday, 19 December 2017

GraphCat seeks to consolidate a leading position in the graphene-based technologies market

This initiative, managed by the ICN2 and scientifically coordinated by the ICN2 and ICFO, will promote a strong community to develop cutting-edge graphene technologies for and by Catalan industry. It was presented on 4 December this year at the ICN2, in an event to kick start the creation of a project portfolio that simultaneously drives progress and showcases regional excellence.

Friday, 03 November 2017

100xCiencia2: Co-creating Value in Scientific Research

100xCiencia.2 was held in Alicante yesterday and today. It brought together the vanguard of Spanish research: the Severo Ochoa and María de Maeztu centers of excellence. The meeting was opened by Carmen Vela, Secretary of State for Research, Development and Innovation, and she highlighted the importance of approaching science and business: "Without transfer there is no innovation and without innovation there is no future"